2010TumoriRequires access

Omeprazole reverses the drug resistance in cisplatin-resistant human lung adenocarcinoma cell line A549/DDP

Da Jiang

Open publisher page 0 citations

Abstract

Objective:To study the effects of omeprazole(OME),a nonspecific inhibitor of vacuolar(H+)-ATPase,in reversing the cisplatin resistance of human lung adenocarcinoma cell line A549/DDP and elucidate the possible mechanism.Methods:A549/DDP were pretreated with OME at non-toxic concentration of 4 μg/mL for 24 h and then incubated with cisplatin(DDP) 2 μg/mL.Cell proliferation was measured with MTT assays.The intracellular pH was detected using laser scanning confocal microscopy(LSCM).The intracellular Bcl-2 and PTEN protein expressions were measured using flow cytometry(FCM).The mRNA expressions of V-ATPase,Bcl-2,and PTEN were detected using semi-quantitative reverse transcription polymerase chain reaction(RT-PCR).Results:OME reversed the drug resistance of A549/DDP cells.The reversal multiple was 1.45(P0.01).LSCM indirectly showed that the intracellular pH was decreased after OME pretreatment.The expression of Bcl-2 in A549/DDP cells was decreased(P0.01),but the expression of PTEN was increased(P0.01).The relative expressions of V-ATPase mRNA were 0.88±0.00 and 0.99±0.00 in A549 and A549/DDP cells,respectively(P0.01).The relative expressions of V-ATPase mRNA of A549/DDP cells were 1.09±0.00 and 1.05±0.02 in OME-treated group and OME-untreated group.RT-PCR assay showed that pretreatment with OME for 24 h inhibited the relative expressions of Bcl-2 mRNA in A549/DDP cells and increased the PTEN mRNA expression(P0.01).Conclusion:The V-ATPase mRNA is over-expressed in A549/DDP cells.OME partly reverses the drug resistance of A549/DDP cells.The action mechanism may be related with up-regulation of PTEN expression and down-regulation of Bcl-2 expression.

About this research paper

What this paper is about

Objective:To study the effects of omeprazole(OME),a nonspecific inhibitor of vacuolar(H+)-ATPase,in reversing the cisplatin resistance of human lung adenocarcinoma cell line A549/DDP and elucidate the possible mechanism.Methods:A549/DDP were pretreated with OME at non-toxic concentration of 4 μg/mL for 24 h and then incubated with cisplatin(DDP) 2 μg/mL.Cell proliferation was measured with MTT assays.The intracellular pH was detected using laser scanning confocal microscopy(LSCM).The intracellular Bcl-2 and PTEN protein expressions were measured using flow cytometry(FCM).The mRNA expressions of V-ATPase,Bcl-2,and PTEN were detected using semi-quantitative reverse transcription polymerase chain reaction(RT-PCR).Results:OME reversed the drug resistance of A549/DDP cells.The reversal multiple was 1.45(P0.01).LSCM indirectly showed that the intracellular pH was decreased after OME pretreatment.The expression of Bcl-2 in A549/DDP cells was decreased(P0.01),but the expression of PTEN was increased(P0.01).The relative expressions of V-ATPase mRNA were 0.88±0.00 and 0.99±0.00 in A549 and A549/DDP cells,respectively(P0.01).The relative expressions of V-ATPase mRNA of A549/DDP cells were 1.09±0.00 and 1.05±0.02 in OME-treated group and OME-untreated group.RT-PCR assay showed that pretreatment with OME for 24 h inhibited the relative expressions of Bcl-2 mRNA in A549/DDP cells and increased the PTEN mRNA expression(P0.01).Conclusion:The V-ATPase mRNA is over-expressed in A549/DDP cells.OME partly reverses the drug resistance of A549/DDP cells.The action mechanism may be related with up-regulation of PTEN expression and down-regulation of Bcl-2 expression.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective:To study the effects of omeprazole(OME),a nonspecific inhibitor of vacuolar(H+)-ATPase,in reversing the cisplatin resistance of human lung adenocarcinoma cell line A549/DDP and elucidate the possible mechanism.Methods:A549/DDP were pretreated with OME at non-toxic concentration of 4 μg/mL for 24 h and then incubated with cisplatin(DDP) 2 μg/mL.Cell proliferation was measured with MTT assays.The intracellular pH was detected using laser scanning confocal microscopy(LSCM).The intracellular Bcl-2 and PTEN protein expressions were measured using flow cytometry(FCM).The mRNA expressions of V-ATPase,Bcl-2,and PTEN were detected using semi-quantitative reverse transcription polymerase chain reaction(RT-PCR).Results:OME reversed the drug resistance of A549/DDP cells.The reversal multiple was 1.45(P0.01).LSCM indirectly showed that the intracellular pH was decreased after OME pretreatment.The expression of Bcl-2 in A549/DDP cells was decreased(P0.01),but the expression of PTEN was increased(P0.01).The relative expressions of V-ATPase mRNA were 0.88±0.00 and 0.99±0.00 in A549 and A549/DDP cells,respectively(P0.01).The relative expressions of V-ATPase mRNA of A549/DDP cells were 1.09±0.00 and 1.05±0.02 in OME-treated group and OME-untreated group.RT-PCR assay showed that pretreatment with OME for 24 h inhibited the relative expressions of Bcl-2 mRNA in A549/DDP cells and increased the PTEN mRNA expression(P0.01).Conclusion:The V-ATPase mRNA is over-expressed in A549/DDP cells.OME partly reverses the drug resistance of A549/DDP cells.The action mechanism may be related with up-regulation of PTEN expression and down-regulation of Bcl-2 expression.

Key concepts: A549 cell, Cisplatin, Molecular biology, Cell culture, Flow cytometry, Intracellular, Chemistry, PTEN

Related papers

Back to paper searchBrowse research topicsOriginal source
Omeprazole reverses the drug resistance in cisplatin-resistant human lung adenocarcinoma cell line A549/DDP — Research Paper | ScholarLens